Abstract
Alterations in the cannabinoid receptor 1 (CB1) are implicated in the development of psychopathologies. However, prior CB1 studies have shown discrepant results in postmortem brain samples obtained from patients with mental health disorders. These studies largely accounted for CB1 present on inhibitory boutons, yet it is known that CB1 participates in both depolarization-induced suppression of inhibition and excitation. Thus, examining cell type–specific CB1 alterations may offer clarity to prior findings and increase our insight into CB1’s influences on excitatory-inhibitory (E/I) balance in healthy and illness states.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
